Staphylococcal Enterotoxin A Induction of Pro-inflammatory Cytokines and Lethality in Mice is Primarily Dependent on MyD88
Overview
Affiliations
Staphylococcal enterotoxin (SE) -induced toxic shock is triggered by inflammatory cytokine signal amplification after SE binding to major histocompatibility complex class II molecules on antigen-presenting cells and T-cell receptors. Identifying host cellular elements contributing to this pro-inflammatory signal amplification is critical for developing a strategy for therapeutic intervention. Myeloid differentiation primary-response protein 88 (MyD88) is an intracellular signalling adaptor protein primarily known for mediating pro-inflammatory cytokine responses. We investigated the role of MyD88 in staphylococcal enterotoxin A (SEA) -treated cell cultures and mouse models of toxic shock. Our results demonstrated that elevated levels of tumour necrosis factor-alpha, interferon-gamma, interleukin-1alpha/beta (IL-1alpha/beta), IL-2 and IL-6 production correlated with up-regulation of MyD88 after treatment of spleen cells and mice with SEA alone or in combination with lipopolysaccharide (LPS). The SEA-induced lethality was also observed in (LPS-independent) D-galactosamine-sensitized mice. While LPS potentiated SEA-induced cytokine responses, D-galactosamine treatment had no additive effect. Most importantly, our results demonstrated that MyD88(-/-) mice were resistant to SEA-induced toxic shock and had reduced pro-inflammatory cytokine responses. These results suggest that SEA-induced lethality is primarily dependent on MyD88. Our findings offer an important insight on potential therapeutic treatment of SEA-induced toxic shock targeting MyD88.
Effect of Polyphenols on Inflammation Induced by Membrane Vesicles from .
Oura Y, Shimamura Y, Kan T, Masuda S Cells. 2024; 13(5.
PMID: 38474351 PMC: 10931263. DOI: 10.3390/cells13050387.
The Safety of Bacteriophages in Treatment of Diseases Caused by Multidrug-Resistant Bacteria.
Chung K, Nang S, Tang S Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895818 PMC: 10610463. DOI: 10.3390/ph16101347.
Toxicity of combined exposure to acrylamide and .
Shimamura Y, Yui T, Horiike H, Masuda S Toxicol Rep. 2022; 9:876-882.
PMID: 36518387 PMC: 9743448. DOI: 10.1016/j.toxrep.2022.04.018.
Doub J Infect Drug Resist. 2022; 14:5629-5637.
PMID: 34992389 PMC: 8711558. DOI: 10.2147/IDR.S341265.
Saikh K Immunol Res. 2021; 69(2):117-128.
PMID: 33834387 PMC: 8031343. DOI: 10.1007/s12026-021-09188-2.